First Trust Mid Cap Growth AlphaDEX Fund Stock Forecast, Price & News

First Trust Mid Cap Growth AlphaDEX Fund's stock was trading at $39.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FNY shares have increased by 54.3% and is now trading at $60.73.
View which stocks have been most impacted by COVID-19.

Wall Street analysts have given First Trust Mid Cap Growth AlphaDEX Fund a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but First Trust Mid Cap Growth AlphaDEX Fund wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

First Trust Mid Cap Growth AlphaDEX Fund announced a quarterly dividend on Wednesday, September 23rd. Stockholders of record on Friday, September 25th will be paid a dividend of $0.09 per share on Wednesday, September 30th. This represents a $0.36 annualized dividend and a yield of 0.59%. The ex-dividend date is Thursday, September 24th. This is a positive change from First Trust Mid Cap Growth AlphaDEX Fund's previous quarterly dividend of $0.00.
View First Trust Mid Cap Growth AlphaDEX Fund's dividend history.

First Trust Mid Cap Growth AlphaDEX Fund saw a drop in short interest in October. As of October 30th, there was short interest totaling 20,100 shares, a drop of 60.5% from the October 15th total of 50,900 shares. Based on an average daily trading volume, of 69,600 shares, the days-to-cover ratio is presently 0.3 days.
View First Trust Mid Cap Growth AlphaDEX Fund's Short Interest.

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Mid Cap Growth AlphaDEX Fund investors own include Adobe (ADBE), Erie Indemnity (ERIE), Exact Sciences (EXAS), First Trust Dow Jones Internet Index Fund (FDN), IDEXX Laboratories (IDXX), Kinsale Capital Group (KNSL), Mastercard (MA), Square (SQ), Veracyte (VCYT) and AMN Healthcare Services (AMN).

First Trust Mid Cap Growth AlphaDEX Fund trades on the NASDAQ under the ticker symbol "FNY."

First Trust Mid Cap Growth AlphaDEX Fund's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wells Fargo & Company MN (8.59%), Morgan Stanley (8.49%), LPL Financial LLC (4.54%), Raymond James Financial Services Advisors Inc. (2.37%), Savior LLC (1.87%) and Kestra Advisory Services LLC (1.97%).

FNY stock was sold by a variety of institutional investors in the last quarter, including First Heartland Consultants Inc., Savior LLC, Financial Advocates Investment Management, Cetera Investment Advisers, Sigma Planning Corp, Commonwealth Equity Services LLC, First Allied Advisory Services Inc., and Envestnet Asset Management Inc..

FNY stock was acquired by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC, Raymond James Financial Services Advisors Inc., Wells Fargo & Company MN, LPL Financial LLC, Raymond James & Associates, First Trust Advisors LP, Kestra Private Wealth Services LLC, and Holloway Wealth Management LLC.

Shares of FNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of FNY stock can currently be purchased for approximately $60.73.

First Trust Mid Cap Growth AlphaDEX Fund has a market capitalization of $431.18 million.